Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment of prostate and renal cancer with oral drugs (abiratarone and antiangiogenic agents): positioning statement from the Spanish Association of Urology.
Villavicencio H, Hernández C, Gómez A, Cózar JM, Rodríguez-Antolín A, Prieto L, de Cabo M, Malet JM, Extramiana J, Mata J, Arrabal M, Server G, Solsona E, Del Valle JI, Miguélez E, Gutiérrez E, Elizalde A, Mateos J, Artiles JL, Jiménez-Cidre M, Nalda LM, Cruz N, Ozonas M, Caffaratti J, Esteban M, Unda M, Reina C, Alvarez-Ossorio JL, Lledó E, Angulo JC. Villavicencio H, et al. Actas Urol Esp. 2013 Jun;37(6):321-3. doi: 10.1016/j.acuro.2013.04.001. Epub 2013 May 23. Actas Urol Esp. 2013. PMID: 23706692 English, Spanish. No abstract available.
Extrauterine Retroperitoneal Leiomyomas: 3 Case Reports and Review of the Literature.
Juste Álvarez S, Miranda Utrera NR, Duarte Ojeda JM, Sopeña Sutil R, Gil Moradillo J, Guerrero-Ramos F, Hernández-Arroyo M, Santos Pérez De La Blanca R, Rodríguez Antolín A, Gomez Del Cañizo C. Juste Álvarez S, et al. Urol Int. 2023;107(8):814-818. doi: 10.1159/000530213. Epub 2023 May 30. Urol Int. 2023. PMID: 37253342 Review.
Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer.
Chi KN, Agarwal N, Bjartell A, Chung BH, Pereira de Santana Gomes AJ, Given R, Juárez Soto Á, Merseburger AS, Özgüroğlu M, Uemura H, Ye D, Deprince K, Naini V, Li J, Cheng S, Yu MK, Zhang K, Larsen JS, McCarthy S, Chowdhury S; TITAN Investigators. Chi KN, et al. N Engl J Med. 2019 Jul 4;381(1):13-24. doi: 10.1056/NEJMoa1903307. Epub 2019 May 31. N Engl J Med. 2019. PMID: 31150574 Free article. Clinical Trial.
[Ultrasonography in urology].
Passas Martínez J, Rodríguez Antolín A, de la Rosa S. Passas Martínez J, et al. Actas Urol Esp. 2002 Oct;26(9):650-65. doi: 10.1016/s0210-4806(02)72843-x. Actas Urol Esp. 2002. PMID: 12508459 Review. Spanish.
[National prostate cancer registry 2010 in Spain].
Cózar JM, Miñana B, Gómez-Veiga F, Rodríguez-Antolín A, Villavicencio H, Cantalapiedra A, Pedrosa E. Cózar JM, et al. Actas Urol Esp. 2013 Jan;37(1):12-9. doi: 10.1016/j.acuro.2012.06.006. Epub 2012 Oct 26. Actas Urol Esp. 2013. PMID: 23102541 Spanish.
Factors that predict the development of bone metastases due to prostate cancer: Recommendations for follow-up and therapeutic options.
Rodríguez-Antolín A, Gómez-Veiga F, Alvarez-Osorio JK, Carballido-Rodriguez J, Palou-Redorta J, Solsona-Narbón E, Sánchez-Sánchez E, Unda M. Rodríguez-Antolín A, et al. Actas Urol Esp. 2014 May;38(4):263-9. doi: 10.1016/j.acuro.2013.09.002. Epub 2013 Oct 21. Actas Urol Esp. 2014. PMID: 24156932 Review. English, Spanish.
Pre-chemotherapy abiraterone acetate. A proposal of a treatment algorithm in castration resistant prostate cancer.
Arrabal-Martín M, Anglada-Curado F, Cózar-Olmo JM, Soler-Martínez J, Moreno-Jiménez J, Castiñeiras-Fernández J, Ledo-Cepero MJ, Beardo-Villar P, Requena-Tapia MJ, Zuluaga-Gómez A; Grupo AAyEU. Arrabal-Martín M, et al. Actas Urol Esp. 2014 Jun;38(5):327-33. doi: 10.1016/j.acuro.2013.10.008. Epub 2013 Dec 15. Actas Urol Esp. 2014. PMID: 24342031 Review. English, Spanish.
130 results